Delivery Order SPE2DB22D1017-SPE2DB25FG7DV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,818.40 to AmerisourceBergen Drug Corp for the supply of Timolol 0.5% Gel-Solution 5mL, a topical ophthalmic medication commonly used to treat glaucoma and ocular hypertension. This firm fixed-price delivery order, issued on August 8, 2025, was competitively awarded with no set-aside designation and carries an ultimate completion date of August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $10,963.88 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML, an ophthalmic medication commonly used to treat glaucoma and ocular hypertension. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order contract valued at $31,449.71 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML, a topical ophthalmic medication used in treating glaucoma and ocular hypertension. This firm fixed price delivery order was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order valued at $10,886.71 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker medication commonly used to treat glaucoma and ocular...
- The Defense Logistics Agency awarded a delivery order valued at $4,540.02 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor...
- The Defense Logistics Agency awarded a delivery order valued at $11,953.10 to AmerisourceBergen Drug Corp for Timolol 0.5% gel-solution in 5ml units. This non-competitive, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker medication primarily used for glaucoma treatment and post-operative eye care,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a contract ceiling value of $4,887.48. This is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Timolol 0.5% gel-solution, a pharmaceutical product used for the treatment of glaucoma. The contract has a ceiling value of $2,026.35 and a completion date of March 27, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a ceiling value of $1,217.05. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Timolol 0.5% gel-solution in 5ml units, with a ceiling value of $2,263.62 and a firm fixed price structure. This delivery order, which is not set-aside and represents a competitively awarded contract, will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 23, 2025. The contract is a...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG7DVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,633.77 to AmerisourceBergen Drug Corp for the supply of Timolol 0.25% Gel-Solution 5ML, an ophthalmic medication used to treat glaucoma and ocular hypertension. The contract, awarded on July 11, 2025, with an ultimate completion date of July 14, 2025, was competitively awarded without set-aside designation under firm fixed-price terms. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's status as a major pharmaceutical distributor and critical federal medical procurement vendor is evidenced by its extensive portfolio of competitively awarded federal contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/11/25 |